USA Financial Formulas’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$441 499
2026
Q1
$441 Hold
3
﹤0.01% 403
2025
Q4
$585 Buy
+3
New +$714 ﹤0.01% 354
2024
Q1
Sell
-33
Closed -$3.48K 396
2023
Q4
$3.48K Sell
33
-2,233
-99% -$244K ﹤0.01% 277
2023
Q3
$240K Buy
+2,266
New +$262K 0.36% 74
2021
Q4
Sell
-1,658
Closed -$144K 467
2021
Q3
$144K Buy
1,658
+974
+142% +$86K 0.13% 133
2021
Q2
$53K Sell
684
-554
-45% -$43.4K 0.04% 216
2021
Q1
$87K Sell
1,238
-176
-12% -$11.4K 0.07% 174
2020
Q4
$91K Buy
1,414
+1,373
+3,349% +$81.7K 0.07% 148
2020
Q3
$2K Hold
41
﹤0.01% 221
2020
Q2
$2K Buy
+41
New +$2.17K ﹤0.01% 127
2017
Q4
Sell
-5,507
Closed -$266K 317
2017
Q3
$266K Sell
5,507
-739
-12% -$36.8K 0.06% 234
2017
Q2
$313K Sell
6,246
-486
-7% -$22.1K 0.08% 207
2017
Q1
$300K Buy
+6,732
New +$280K 0.07% 190

Other funds holding ORCL

USA Financial Formulas's ORCL Position: Q2 2026 in Review

USA Financial Formulas sold out of Oracle (ORCL) in Q2 2026, closing a stake of 3 shares — an estimated $441 sold.

USA Financial Formulas first reported a position in ORCL in Q1 2017 and held it in 13 quarters. The position peaked at $313K in Q2 2017. 3,527 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • USA Financial Formulas reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • USA Financial Formulas sold 3 Oracle shares in Q2 2026, an estimated $441.
  • USA Financial Formulas first reported a position in Oracle in Q1 2017 and held it in 13 quarters.
  • USA Financial Formulas's Oracle position peaked at $313K in Q2 2017.
  • 3,527 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.